MedPath

Assessment of the Role of Incisura Biopsy in the Staging of Chronic Gastritis

Recruiting
Conditions
Chronic; Gastritis, Atrophic
Registration Number
NCT05744596
Lead Sponsor
Clinical Hospital Colentina
Brief Summary

This prospective multicenter study investigates the added benefit of incisura biopsy to correct identification of patients with high-risk chronic gastritis (OLGA stages III-IV). It compares a biopsy protocol with and without a single incisura biopsy in a non-inferiority design.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
400
Inclusion Criteria
  • indication to perform upper GI endoscopy for diagnosis or surveillance
Exclusion Criteria
  • lack of informed consent, previously diagnosed advanced gastric cancer, incomplete endoscopy, surgically altered stomach

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
prevalence of OLGA III-IVat time of enrollment
Secondary Outcome Measures
NameTimeMethod
prevalence of OLGIM III-IVat time of enrollment

Trial Locations

Locations (1)

Colentina Clinical Hospital

🇷🇴

Bucharest, Romania

Colentina Clinical Hospital
🇷🇴Bucharest, Romania
Andrei Voiosu, PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.